Peroxinitrite and Malondialdehyde as Biomarkers for Overactive Bladder.

Area of Science:

• Urology
• Biochemistry
• Clinical Diagnostics

Background:

• Overactive bladder (OAB) is a condition characterized by urinary urgency.
• Oxidative stress markers, including malondialdehyde (MDA) and peroxynitrite (ONOO), are implicated in various pathologies.
• Investigating novel biomarkers for OAB diagnosis and treatment monitoring is crucial.

Purpose of the Study:

• To compare urine MDA and ONOO levels in patients with OAB versus healthy individuals.
• To assess the changes in these oxidative stress markers following antimuscarinic drug treatment in OAB patients.

Main Methods:

• An observational study was conducted with diagnosed OAB patients and healthy controls.
• Urinary MDA and ONOO levels were measured using established biochemical assays.
• OAB patients received antimuscarinic therapy (propiverine 30 mg) for three months, with marker re-analysis.

Main Results:

• Urine MDA levels were significantly higher in OAB patients compared to controls (p=0.036).
• No significant difference in urine ONOO levels was observed between OAB patients and controls (p > 0.05).
• Antimuscarinic therapy did not alter MDA levels but led to a significant increase in ONOO levels (p=0.013).

Conclusions:

• Malondialdehyde (MDA) shows potential as a diagnostic biomarker for overactive bladder (OAB).
• Peroxynitrite (ONOO) did not demonstrate significant utility in OAB diagnosis in this study.
• Neither MDA nor ONOO proved effective as biomarkers for monitoring antimuscarinic therapy in OAB.